| answer text |
<p>NHS England specialised commissioning only reports the costs of the National Health
Service specialised commissioning services by region and hub for treating sickle cell
disease, which includes sickle cell anaemia. This information is shown in the following
table. The data is not broken down by clinical commissioning group (CCG) area. This
information does not include non-specialised activity that CCGs may fund. Information
was not collected prior to 2015/16 and information for 2018/19 is not currently available.</p><p>
</p><p>Costs of NHS specialised commissioning services by region and hub for treating
sickle cell disease</p><table><tbody><tr><td><p>Region</p></td><td><p>Hub</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td></tr><tr><td><p>
</p></td><td><p> </p></td><td><p>£ million</p></td><td><p>£ million</p></td><td><p>£
million</p></td></tr><tr><td><p>London</p></td><td><p> </p></td><td><p>29.9</p></td><td><p>31.0</p></td><td><p>44.8</p></td></tr><tr><td><p>
</p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>Midlands
and East</p></td><td><p>East of England</p></td><td><p>1.6</p></td><td><p>1.7</p></td><td><p>3.3</p></td></tr><tr><td><p>
</p></td><td><p>East Midlands</p></td><td><p>0.8</p></td><td><p>0.8</p></td><td><p>1.4</p></td></tr><tr><td><p>
</p></td><td><p>West Midlands</p></td><td><p>2.7</p></td><td><p>2.5</p></td><td><p>3.2</p></td></tr><tr><td><p>Midlands
and East Total</p></td><td><p> </p></td><td><p>5.1</p></td><td><p>5.0</p></td><td><p>7.9</p></td></tr><tr><td><p>
</p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>North</p></td><td><p>North
East</p></td><td><p>0.1</p></td><td><p>0.2</p></td><td><p>0.2</p></td></tr><tr><td><p>
</p></td><td><p>North West</p></td><td><p>2.8</p></td><td><p>2.3</p></td><td><p>2.3</p></td></tr><tr><td><p>
</p></td><td><p>Yorkshire & Humber</p></td><td><p>1.1</p></td><td><p>0.5</p></td><td><p>0.9</p></td></tr><tr><td><p>North
Total</p></td><td><p> </p></td><td><p>4.0</p></td><td><p>3.0</p></td><td><p>3.4</p></td></tr><tr><td><p>
</p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>South</p></td><td><p>South
East</p></td><td><p>1.8</p></td><td><p>1.9</p></td><td><p>2.6</p></td></tr><tr><td><p>
</p></td><td><p>South West</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.7</p></td></tr><tr><td><p>
</p></td><td><p>Wessex</p></td><td><p>0.5</p></td><td><p>0.5</p></td><td><p>0.9</p></td></tr><tr><td><p>South
Total</p></td><td><p> </p></td><td><p>2.5</p></td><td><p>2.5</p></td><td><p>4.2</p></td></tr><tr><td><p>
</p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>
</p></td><td><p> </p></td><td><p>41.6</p></td><td><p>41.5</p></td><td><p>60.4</p></td></tr></tbody></table><p>
</p><p>Source: Costs extracted from the annual CCG exercise.</p><p>Between 2012/13
and 2018/19, approximately 117,000 patients were admitted to hospital with a primary
diagnosis of sickle cell disease. Information for years prior to 2012/13 is not available.
NHS England has advised that it is unable to separate expenditure between admitted
patient care episodes and the overall costs provided in the table without incurring
disproportionate cost.</p>
|
|
